Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Tandem radiation therapy effective in prostate cancer patients with no treatment options

Reports of new cancer treatments often raise high hopes and expectations, particularly, of course, among cancer patients and their families.

26 Nov 2019

Cancer patients have higher risk of cardiovascular death

A new study says that over 10% of patients with cancer die of unrelated cardiovascular disease (CVD) rather than their cancers.

25 Nov 2019

Predicting opioid-related problems among cancer survivors

Opioids play an important role in how cancer patients manage pain, but the ongoing opioid epidemic has raised concerns about their potential for abuse.

22 Nov 2019

Statin use may reduce risk of developing lethal prostate cancer

New research led by Queen's University Belfast has found that men who are on statins, medicine used to lower blood cholesterol, may have a reduced risk of developing a more lethal form of prostate cancer.

21 Nov 2019

Prostate cancer patients receiving care at MultiD clinic more likely to be advised about treatment choices

Newly diagnosed prostate cancer patients have multiple standard-of-care treatment options available, but many are not fully informed of their choices.

19 Nov 2019

Study explores the overall rate of new cancer cases in Canada from 1971 to 2015

The overall rate of new cancer cases is decreasing in men but increasing in women younger than 80 years, and obesity-related cancers are increasing in young people, according to a study on cancer trends in Canada from 1971 to 2015 published in CMAJ (Canadian Medical Association).

18 Nov 2019

Omega-3 supplement continues to protect heart health without increasing prostate cancer risk

Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health.

17 Nov 2019

Research breakthrough may lead to new therapeutic targets for cancers

Computational modeling is the use of computers to simulate and study the behavior of complex systems. Computational approaches are widely adopted in the bioimedical sciences and can be used to sift through large volumes of complex data to extract recurrent patterns that may point to a disease's causes and effects.

15 Nov 2019

Mining 'darkest' parts of the genome in cancer cells yields gold

Mining the rich uncharted territory of the genome or genetic material of a cancer cell has yielded gold for Princess Margaret scientists: new protein targets for drug development against prostate cancer.

15 Nov 2019

Research explains why immunotherapy fails against prostate cancer bone metastases

Prostate cancer that spreads to the bone triggers the destruction of bone tissue that, in turn, thwarts the effectiveness of immune checkpoint inhibitors by blocking the development of T cells that are crucial to successful treatment, researchers from The University of Texas MD Anderson Cancer Center report in Cell.

14 Nov 2019

Study on sea sponge opens up possibilities to create new antitumor drugs

Chemists from Far Eastern Federal University's School of Natural Sciences developed a new method to synthesize biologically active derivatives of fascaplysin -- cytotoxic pigment of a sea sponge. For the first time, they got a sufficient amount of 3-bromofascaplysin and 3,10-dibromofascaplysin, which were known before but were not available for study.

14 Nov 2019

Tips to help parents share family health history with children

Parents spend hours planning to talk with their children about the "birds and bees." But moms and dads often ignore an equally important conversation - discussing their family's overall health history.

13 Nov 2019

TSU researchers develop new approach to diagnose adenocarcinoma

Scientists have developed a new approach to the diagnosis of adenocarcinoma - a malignant tumor of the prostate gland. Artificial intelligence is used to determine oncopathology and determine the stage of the disease with this approach.

13 Nov 2019

Scientists find driver for more deadly prostate cancer

A transcription factor that aids neuron function also appears to enable a cell conversion in the prostate gland that can make an already recurrent cancer even more deadly, scientists say.

13 Nov 2019

New PNNL approach improves accuracy of patient diagnosis dramatically

Artificial intelligence will never replace a doctor. However, researchers at the Department of Energy's Pacific Northwest National Laboratory have taken a big step toward the day when AI can help physicians predict medical events.

12 Nov 2019

Clinical benefit of anticoagulants for atrial fibrillation decreases with age, shows study

The net clinical benefit of anticoagulants for atrial fibrillation (AF) -- one of the most important causes of irregular heartbeats and a leading cause of stroke -- decreases with age, as the risk of death from other factors diminishes their benefit in older patients, according to a study led by researchers at UC San Francisco.

11 Nov 2019

Eight tips to help ensure the success of men's health programs

With November comes Movember, putting the spotlight on men's health, and UBC nursing professor John Oliffe has a few tips that can help ensure the success of men's health programs.

7 Nov 2019

Blood test combined with AI program could speed up diagnosis of brain tumors

Chemical analysis of blood samples, combined with an artificial intelligence program, could speed up the diagnosis of brain tumors, according to research presented at the 2019 NCRI Cancer Conference.

5 Nov 2019

Two-hormone combo test predicts prostate cancer risk

New research presented at the NCRI Cancer Conference, 2019, shows that free testosterone and insulin-like growth factor-1 (IGF-I), when present at high levels in combination, show a higher risk of prostate cancer in men. This finding is important since both these factors can be counteracted, to possibly reduce the risk.

3 Nov 2019

Popular health campaigns aren’t always the most productive, says new study

Researchers have found that just because a public health campaign is popular among the digital community, it doesn’t mean it will produce gains in healthy behavior. This study, published in Lancet Oncology, concludes that in addition to attractive slogans or easy-to-understand captions and images, the relevance of the focused health issue to the target audience and to current guidelines may guide audience behavior.

31 Oct 2019